Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) continues to raise worldwide concerns due to its pandemic potential. Increased MERS cases and no licensed MERS vaccines highlight the need to develop safe and effective vaccines against MERS. We have previously demonstrated that a receptor-binding domain (RBD)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hum Vaccin Immunother
Glavni autori: Wang, Yufei, Tai, Wanbo, Yang, Jie, Zhao, Guangyu, Sun, Shihui, Tseng, Chien-Te K., Jiang, Shibo, Zhou, Yusen, Du, Lanying, Gao, Jimin
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2017
Teme:
Research Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512770/
https://ncbi.nlm.nih.gov/pubmed/28277821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1296994
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items